Research Analysts Offer Predictions for EHC FY2024 Earnings

Encompass Health Co. (NYSE:EHC - Free Report) - Analysts at William Blair increased their FY2024 EPS estimates for shares of Encompass Health in a report issued on Tuesday, October 29th. William Blair analyst J. Haase now anticipates that the company will post earnings of $4.24 per share for the year, up from their previous estimate of $4.10. The consensus estimate for Encompass Health's current full-year earnings is $4.18 per share. William Blair also issued estimates for Encompass Health's Q4 2025 earnings at $1.09 EPS and FY2025 earnings at $4.87 EPS.

Several other analysts also recently issued reports on the company. Stephens restated an "overweight" rating and issued a $105.00 price target on shares of Encompass Health in a research note on Tuesday, August 6th. Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday. Leerink Partnrs upgraded Encompass Health to a "strong-buy" rating in a research note on Wednesday, July 10th. UBS Group boosted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. Finally, Truist Financial reissued a "buy" rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health has an average rating of "Buy" and a consensus price target of $107.11.

Encompass Health Stock Performance

EHC traded up $1.35 on Wednesday, reaching $101.35. The company had a trading volume of 1,205,646 shares, compared to its average volume of 639,027. Encompass Health has a fifty-two week low of $61.08 and a fifty-two week high of $102.36. The stock has a market cap of $10.20 billion, a P/E ratio of 24.36, a P/E/G ratio of 1.45 and a beta of 0.88. The company's fifty day moving average is $93.90 and its 200 day moving average is $88.52. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the firm earned $0.86 EPS. The firm's revenue was up 11.9% compared to the same quarter last year.

Encompass Health declared that its board has initiated a stock repurchase program on Wednesday, July 24th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 5.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's dividend payout ratio (DPR) is currently 16.43%.

Insider Buying and Selling

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the business's stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares in the company, valued at $11,761,839.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Encompass Health

A number of large investors have recently modified their holdings of EHC. QRG Capital Management Inc. grew its stake in Encompass Health by 9.1% in the 3rd quarter. QRG Capital Management Inc. now owns 15,672 shares of the company's stock worth $1,515,000 after buying an additional 1,307 shares in the last quarter. Harbor Capital Advisors Inc. raised its position in Encompass Health by 104.7% during the third quarter. Harbor Capital Advisors Inc. now owns 73,272 shares of the company's stock valued at $7,081,000 after purchasing an additional 37,473 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Encompass Health by 5.5% during the third quarter. Janney Montgomery Scott LLC now owns 11,357 shares of the company's stock worth $1,098,000 after purchasing an additional 597 shares during the last quarter. US Bancorp DE increased its position in shares of Encompass Health by 18.7% during the 3rd quarter. US Bancorp DE now owns 1,259 shares of the company's stock valued at $122,000 after purchasing an additional 198 shares during the last quarter. Finally, First Trust Direct Indexing L.P. raised its holdings in shares of Encompass Health by 11.9% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,851 shares of the company's stock valued at $276,000 after buying an additional 304 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.